X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (229) 229
Publication (33) 33
Book / eBook (8) 8
Book Review (8) 8
Web Resource (6) 6
Book Chapter (3) 3
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (126) 126
pharmacology & pharmacy (85) 85
adult (58) 58
male (58) 58
female (55) 55
microbiology (52) 52
pharmacokinetics (50) 50
index medicus (48) 48
middle aged (45) 45
infectious diseases (42) 42
anti-bacterial agents - pharmacokinetics (41) 41
pharmacology (40) 40
anti-bacterial agents - administration & dosage (35) 35
antibiotics (31) 31
anti-bacterial agents - therapeutic use (26) 26
vancomycin (22) 22
aged (21) 21
adolescent (20) 20
vancomycin - pharmacokinetics (20) 20
infections (18) 18
area under curve (17) 17
microbial sensitivity tests (17) 17
drug administration schedule (16) 16
drug interactions (16) 16
immunology (16) 16
vancomycin - administration & dosage (16) 16
pharmacodynamics (15) 15
bayes theorem (14) 14
models, biological (14) 14
anti-bacterial agents - pharmacology (13) 13
resistant staphylococcus-aureus (13) 13
administration, oral (12) 12
anti-bacterial agents - adverse effects (12) 12
child (12) 12
chromatography, high pressure liquid (12) 12
infection (12) 12
medicine & public health (12) 12
animals (11) 11
anti-bacterial agents - blood (11) 11
anti-infective agents - pharmacokinetics (11) 11
clarithromycin (11) 11
dosage (11) 11
drug therapy (11) 11
efficacy (11) 11
medicine (11) 11
safety (11) 11
toxicology (11) 11
young adult (11) 11
anti-infective agents - administration & dosage (10) 10
bronchoalveolar lavage fluid - chemistry (10) 10
dose-response relationship, drug (10) 10
levofloxacin (10) 10
retrospective studies (10) 10
staphylococcal infections - drug therapy (10) 10
therapy (10) 10
aminoglycosides (9) 9
anti-infective agents (9) 9
azithromycin (9) 9
bacterial infections - drug therapy (9) 9
children (9) 9
disposition (9) 9
drug resistance (9) 9
drug resistance, bacterial (9) 9
half-life (9) 9
infant (9) 9
lung - metabolism (9) 9
monte carlo method (9) 9
pharmacy (9) 9
pneumonia (9) 9
aged, 80 and over (8) 8
community-acquired pneumonia (8) 8
critically-ill patients (8) 8
epithelial lining fluid (8) 8
infusions, intravenous (8) 8
internal medicine (8) 8
pharmaceutical technology (8) 8
resistance (8) 8
skin-structure infections (8) 8
staphylococcal infections - microbiology (8) 8
tissue distribution (8) 8
vancomycin - blood (8) 8
algorithms (7) 7
alveolar macrophages (7) 7
antimicrobial agents (7) 7
antimicrobials (7) 7
bronchoscopy (7) 7
care and treatment (7) 7
child, preschool (7) 7
emerging infectious diseases (7) 7
epithelium - metabolism (7) 7
gentamicin (7) 7
in-vitro activity (7) 7
injections, intravenous (7) 7
k tu pharmacology & pharmacy (7) 7
methicillin-resistant staphylococcus aureus (7) 7
methicillin-resistant staphylococcus aureus - drug effects (7) 7
penetration (7) 7
pharmacology/toxicology (7) 7
research (7) 7
risk factors (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 06/2019
Journal Article
2005, 2nd ed., Infectious disease, ISBN 9781588294555, x, 534
Theory of Contents: Section 1: General Concepts - Introduction to Drug Interactions, Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion,... 
Anti-infective agents | Side effects | Drug interactions | Other branches of medicine | Medicine & Public Health | Infectious Diseases
Book
Clinical Infectious Diseases, ISSN 1058-4838, 09/2015, Volume 61, Issue suppl 2, pp. S35 - S37
Journal Article
2011, 3rd ed., Infectious disease., ISBN 1617792128, xiii, 692
This revised and updated third edition includes five new chapters and delivers a resource that will enhance clinical knowledge of the complex mechanisms,... 
Anti-infective agents | Side effects | Drug interactions | Communicable diseases | Clinical & internal medicine | Anti-infective agents - Side effects
Book
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 04/2019, Volume 74, Issue Supplement_3, pp. iii2 - iii4
Abstract Lefamulin is the first semisynthetic pleuromutilin being developed for oral and intravenous administration. The drug selectively inhibits prokaryotic... 
INFECTIOUS DISEASES | ACUTE BACTERIAL SKIN | COMPOUND | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PLEUROMUTILIN ANTIBIOTIC BC-3781 | ANTIMICROBIAL ACTIVITY | PROGRAM | RESPIRATORY-TRACT INFECTIONS | Supplement Papers
Journal Article
2001, Infectious disease, ISBN 0896037509, xii, 363
Book
Clinical Infectious Diseases, ISSN 1058-4838, 09/2015, Volume 61, p. S38
  Telavancin (TD-6424) was discovered in 2000 and became the first marketed semisynthetic lipoglycopeptide in 2009. This parenteral antibacterial agent has a... 
Peptides | Gram-positive bacteria | Staphylococcus infections | Comparative analysis | Drug dosages
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2015, Volume 61, Issue 6, p. S38
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 637 - 664
The exposure-response relationship of anti-infective agents at the site of infection is currently being re-examined. Epithelial lining fluid (ELF) has been... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Iclaprim | Linezolid | Levofloxacin | Clarithromycin | Cefepime | Gentamicin | Azithromycin | Roxithromycin | Cefdinir | Moxifloxacin | Vancomycin | Teicoplanin | Ceftobiprole | Antibacterials | Amoxicillinclavulanic-acid | Cefditoren | Cefpodoxime-proxetil | Pulmonary-lavage | Meropenem | Interstitial-fluid | Piperacillintazobactam | Cefaclor | Ceftazidime | Netilmicin | Cefpirome | Dirithromycin | Telithromycin | Pharmacology | Erythromycin | Ertapenem | Modithromycin | Cethromycin | Telavancin | Ceftibuten | Tobramycin | Biapenem | Ciprofloxacin | Oritavancin | Pharmacokinetics | Tigecycline | Cefuroxime-axetil | COMMUNITY-ACQUIRED PNEUMONIA | VENTILATOR-ASSOCIATED PNEUMONIA | SEVERE NOSOCOMIAL PNEUMONIA | KETOLIDE ANTIMICROBIAL AGENT | HEALTHY ADULT SUBJECTS | PHARMACOLOGY & PHARMACY | MONTE-CARLO-SIMULATION | RESISTANT STREPTOCOCCUS-PNEUMONIAE | STEADY-STATE PLASMA | CRITICALLY-ILL PATIENTS | IN-VITRO ACTIVITY | Epithelium - metabolism | Humans | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Tissue Distribution | Models, Biological | Body Fluid Compartments - metabolism | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Lung - metabolism | Bronchoalveolar Lavage Fluid - chemistry | Macrophages, Alveolar - metabolism | Anti-Bacterial Agents - administration & dosage | Monte Carlo Method
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2019, Volume 69, Issue Supplement_1, pp. S16 - S22
Abstract Oral and intravenous (IV) omadacycline formulations are approved in the United States for treating acute bacterial skin and skin structure infections... 
omadacycline | INFECTIOUS DISEASES | pharmacodynamics | tetracyclines | pharmacokinetics | MICROBIOLOGY | IMMUNOLOGY | Index Medicus | Supplement
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2014, Volume 58, Issue 1, pp. 309 - 316
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 01/2014, Volume 58, p. S20
  Methicillin-resistant Staphylococcus aureus (MRSA) continues to be associated with significant morbidity and mortality. Vancomycin was the "gold standard" of... 
Pneumonia | Medical treatment | Penicillin | Bacteria | Drug resistance
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 01/2014, Volume 58, pp. S20 - S20
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be associated with significant morbidity and mortality. Vancomycin was the "gold standard" of... 
Journal Article